학술논문
Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
Document Type
Article
Author
Brown, J William L ; Cunniffe, Nick G ; Prados, Ferran; Kanber, Baris; Jones, Joanne L; Needham, Edward; Georgieva, Zoya; Rog, David; Pearson, Owen R; Overell, James; MacManus, David; Samson, Rebecca S; Stutters, Jonathan; ffrench-Constant, Charles; Gandini Wheeler-Kingshott, Claudia A M; Moran, Carla; Flynn, Paul D; Michell, Andrew W; Franklin, Robin J M; Chandran, Siddharthan; Altmann, Daniel R; Chard, Declan T; Connick, Peter; Coles, Alasdair J
Source
In The Lancet Neurology September 2021 20(9):709-720
Subject
Language
ISSN
1474-4422